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Purpose—The purpose of this study was to develop and validate a new comprehensive patient-
reported measure of treatment burden – the Patient Experience with Treatment and Self-
Management (PETS).
Methods—A conceptual framework was used to derive the PETS with items reviewed and 
cognitively tested with patients. A survey battery, including a pilot version of the PETS, was 
mailed to 838 multi-morbid patients from two healthcare institutions for validation.
Results—A total of 332 multi-morbid patients returned completed surveys. Diagnostics 
supported deletion and consolidation of some items and domains. Confirmatory factor analysis 
supported a domain model for scaling comprised of 9 factors: medical information, medications, 
medical appointments, monitoring health, interpersonal challenges, medical/healthcare expenses, 
difficulty with healthcare services, role/social activity limitations, and physical/mental exhaustion. 
Scales showed good internal consistency (alpha range: 0.79 – 0.95). Higher PETS scores, 
indicative of greater treatment burden, were correlated with more distress, less satisfaction with 
medications, lower self-efficacy, worse physical and mental health, and lower convenience of 
healthcare (Ps<.001). Patients with lower health literacy, less adherence to medications, and more 
financial difficulties reported higher PETS scores (Ps<.01).
Conclusion—A comprehensive patient-reported measure of treatment burden can help to better 
characterize the impact of treatment and self-management burden on patient well-being and guide 
care toward minimally disruptive medicine.
Keywords
treatment burden; adherence; questionnaire; self-management; multi-morbidity; validation
Introduction
Treatment burden refers to the personal workload of healthcare, including treatment and 
self-management of chronic health conditions, and the impact of this workload on patient 
functioning and well-being [1-3]. Workload identifies the activities that patients are asked or 
required to do in order to care for their health (e.g., taking medications, maintaining medical 
appointments, monitoring health status, engaging in physical therapy). Impact refers to a 
patient's perception of the effect of the workload on role, social, physical, and psychological 
functioning. Financial challenges, confusion about medical information, and challenges with 
the healthcare system may add to the weight of the burden that is felt by the patient [2-6]. 
High treatment burden is an important clinical issue as evidence suggests that it may 
negatively affect behavioral and clinical outcomes such as adherence [7-11]. Non-adherence 
to medical regimens can lead to more hospitalization and readmissions, higher overall 
healthcare costs, and lower survival rates [12-15]. Clinicians' response to poor patient 
outcomes is often to intensify treatment, which ostensibly reinforces and adds to the existing 
burden [16]. Not surprisingly, burdened patients also report poor quality of life [17-20].
People with multiple chronic conditions may be especially vulnerable to treatment burden. 
One in four American adults have multiple chronic conditions, with the prevalence expected 
to rise by >1% per year until 2030 [21-24]. Many are required to engage in a complex 
variety of medical and self-management activities just to maintain their health status at a 
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given level [16,25]. They are often required to seek care from a variety of providers which 
can lead to care that is fragmented, poorly coordinated [26-28], complex, and straining on 
personal resources [29,16]. To date, there are limited means of assessing patients' ability to 
integrate complex care into their lives. It is against this backdrop that we develop a 
comprehensive measure of treatment burden.
In this report we describe the development and initial validation of the Patient Experience 
with Treatment and Self-Management (PETS), a comprehensive, patient-reported measure 
of treatment burden. The measure is informed by a previously generated conceptual 
measurement framework based largely on qualitative data from patients with multiple 
chronic conditions (see Eton et al. 2015) [3].
Drafting the Measure
The PETS measure was drafted from the previously articulated conceptual framework [3] 
then reviewed by a stakeholder panel consisting of physicians, health services researchers, 
patient advocates and a nurse practitioner. After revision based on feedback from the panel, 
a new draft was submitted to cognitive pre-testing with patients with multiple chronic 
conditions. A complete description of this developmental process can be found in a 
supplement to this report (see Online Resource Supplement 1). The resulting 78-item PETS 
measure submitted to validation consisted of the following fifteen content domains (and 
number of items within each): learning about health conditions and care (3), medications (5), 
difficulty with taking medications (6), medical appointments (6), monitoring health (2), 
exercise or physical therapy (5), diet (4), medical equipment (3), interpersonal challenges 
(4), medical/healthcare expenses (8), confusion/concern about medical information (6), 
healthcare providers (7), difficulty with healthcare services (7), role and social activity 
limitations (6), and physical/mental exhaustion (6). Items use either a 4- or 5-point ordered, 
categorical response scale depending on content domain (e.g., very easy to very difficult, not 
at all to very much, strongly agree to strongly disagree, never to always).
Validation of the PETS Measure
Sample
The study sample was obtained from two clinical sites: the Hennepin County Medical 
Center (HCMC: Minneapolis, MN) and the Mayo Clinic (Rochester, MN). HCMC is a 
public “safety net” hospital located in urban Minneapolis that provides care for low income, 
uninsured, and vulnerable persons. The Mayo Clinic is a multi-specialty integrated practice 
in southeastern Minnesota. Recruitment from both sites contributed to increased diversity of 
study participants. In selecting the sample for initial validation we assumed that patients 
with (a) more chronic conditions and (b) more recent encounters with their healthcare 
provider(s) for these conditions were more likely to be experiencing treatment burden. 
Hence, patients meeting the following criteria were eligible: (1) ≥21 years old, (2) assigned 
to a primary care provider at either the Mayo Clinic or HCMC, (3) medical record-
confirmed diagnoses of two or more chronic conditions (specifically conditions likely to 
require burdensome treatment and/or self-management strategies [30,27,31,32]) with these 
diagnoses listed on billing encounters of the past 3 years, and (4) at least one medical 
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record-confirmed encounter with a Mayo Clinic or HCMC provider within the past 18 
months for one or more of the selected chronic conditions. Patients lacking English language 
proficiency were excluded. The sampling frame was stratified based on number of diagnosed 
conditions (2, 3, or 4+), number of encounters with a provider within the past 18 months 
(1-8, 9-17, 18+), and age (<65 or ≥65). This resulted in eighteen strata from which patients 
were equally sampled across the two clinical sites.
Procedure
A self-administered, paper-and-pencil formatted survey battery was produced by the Mayo 
Clinic Survey Research Center. The battery consisted of the 78-item PETS measure as well 
as several established scales, including a 5-item chronic condition distress scale adapted 
from the Diabetes Distress Scale [33] and specified generally for “health problems” (L. 
Fisher, personal communication), the 5-item Side Effects and 3-item Convenience subscales 
of the Treatment Satisfaction Questionnaire for Medication (TSQM) [34], the 8-item 
Perceived Medical Condition Self-Management scale (PMCSM), a general dispositional 
measure of self-efficacy or perceived competence in managing one's health condition [35], 
and the Patient-Reported Outcomes Measurement Information System (PROMIS) Global-10 
featuring global physical health (GPH) and global mental health (GMH) summary scores 
[36]. All are reliable and valid measures in patients with chronic illnesses [34,36,37,33]. 
Demographic characteristics (age, race/ethnicity, education, and occupational status), 
personal health-related issues (i.e., numbers of prescription medications, perceived 
economic hardship due to medical care), and several other health-relevant concepts (i.e., 
health literacy, medication adherence, and convenience of healthcare services) [38-40] were 
assessed using targeted single items. Gender, number and types of chronic conditions, and 
number of recent encounters with a provider (last 18 months) were extracted from the 
electronic medical record.
Mailings prepared by each site included the survey battery, a cover letter, a small gift to 
encourage participation (designer pen or $3 gift card), and a stamped return envelope. 
Signed consent and privacy authorization were not required as the study was approved as 
exempt by both the Mayo and HCMC Institutional Review Boards. A total of 838 surveys 
were mailed based on the stratified random samples generated and expected minimum return 
rate of 40-50%. To maximize returns, a second mailing to non-respondents occurred three 
weeks later.
Analyses
Item diagnostics—Prior to scaling analyses (i.e., factor analysis), item responses were 
first reviewed for missing data. Items with extensive amounts of missing data (≥25%) were 
set aside as low sample sizes can create unstable factor structures. Next, the inter-item 
correlation matrix of all PETS items (78 × 78) was examined to determine possible within 
domain item redundancies and indicate items that might lack conceptual fit to their initially 
hypothesized domain. Possible item redundancies within a domain were flagged by an item-
to-item correlation magnitude suggestive of content overlap (Spearman rho ≥ 0.80). These 
items were candidates for exclusion. Items showing equivalent or higher cross-domain than 
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within-domain item correlations were inspected for possible deletion or re-mapping prior to 
factor analysis.
Factor structure—After reviewing the item diagnostics, a set of competing confirmatory 
factor analyses (CFAs) were performed iteratively. The CFAs were conducted using MPLUS 
version 7.2 [41] with the implementation of polychoric correlation matrices and weighted 
least squares with adjustments for mean and variance (WLSMV) estimation, which is 
appropriate for the evaluation of ordered categorical data. The initially hypothesized factor 
structure was the domain conceptual framework slightly modified by the results of the item 
diagnostics review. Subsequent models tested more parsimonious solutions (i.e., fewer 
factors). Several indices were used to establish the fit of the models to the data, including the 
Comparative Fit Index (CFI: > 0.9 indicating good fit), Tucker-Lewis Index (TLI: > 0.95 
indicating good fit), and the Root-Mean-Square Error of Approximation (RMSEA: < 0.10 
desirable) [42,43]. Results were used to test whether domain scoring by the conceptual 
framework could be justified or whether a simpler model is more appropriate.
Scoring of the PETS—All PETS scales were scored such that a higher score indicates 
greater treatment burden; thus, positively-worded items were reverse-coded before scoring. 
Following this, raw scale scores were generated by summing the unweighted items within 
each factor supported by CFA. Given that some items will query issues that may not be 
applicable to all respondents, aggregated scale scores were prorated for missing item data, 
provided that at least 50% of the total number of items in a scale were non-missing (e.g., 2 
of 3 items, 3 of 5 items, etc.). Prorating in this manner has been used with other patient-
reported measures [44]. To further facilitate interpretation, each raw scale score was 
transformed to a standardized 0 to 100 scale using the following formula: [((raw score - 
lowest possible raw score) / possible raw score range) × 100].
Reliability and validity—Internal consistency reliability was computed for all PETS 
scales using Cronbach's alpha, with alphas ≥ 0.70 indicating adequate reliability [45]. 
Construct validity was determined by correlating PETS domain scores with scores from 
established measures of conceptually-related constructs (i.e., convergence). For these 
analyses, we hypothesized that higher PETS scores would be associated with greater chronic 
condition distress (Chronic Condition Distress scale), greater bother of medication side 
effects (TSQM side effects), less medication convenience (TSQM convenience), lower self-
efficacy for managing chronic illness (PMCSM), poorer overall physical and mental health 
(PROMIS-10), and lower convenience of healthcare services. A correlation magnitude of at 
least moderate-level (Spearman rho ≥ 0.30) and in the hypothesized direction would 
represent evidence of construct validity [46]. Validity was also determined by correlating 
PETS scores with data extracted from the medical record including, number of chronic 
conditions and number of recent encounters with healthcare providers. We hypothesized that 
higher PETS scores would be associated with having more diagnosed conditions and more 
recent encounters with medical providers. Finally, known-groups validity was evaluated by 
comparing group means using independent samples t-tests. In comparing known groups, we 
hypothesized that patients who self-reported lower health literacy, less adherence to 
prescribed medications, and more financial difficulties due to their physical condition/
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medical care would have higher PETS scores. Given the large number of analyses, a 
relatively conservative alpha level of 0.01 was set for all correlations and group 
comparisons. Analyses were conducted in IBM SPSS Statistics version 20®.
Results
Characteristics of the sample
Of 838 mailed surveys, 332 were completed and returned (40% response). Demographic, 
medical, and other health-related characteristics of the sample are identified in Table 1. 
There were slightly more female (56%) than male participants, with a mean age of 66 years 
(range: 26-90). The majority of respondents identified themselves as white (73%), were 
married or living with a partner (58%), and had at least some formal college or university 
education (70%). Among variables extracted from the electronic medical record, the median 
number of diagnosed conditions was 3 and the median number of encounters with a medical 
provider in the past 18 months was 13.5. The most common diagnoses were hypertension 
(77%), lipid metabolic disorders (76%), diabetes (36%), osteoarthritis (36%), and coronary 
artery disease (19%).
To test for possible responder bias, we assessed whether survey respondents were different 
from non-respondents by comparing frequency distributions of number of conditions (2, 3, 
4+), number of encounters (1-8, 9-17, 18+), gender (female, male) and age (<65, ≥65), 
variables that were all obtained from the medical record. There were no significant 
differences between responders and non-responders in the number of diagnosed conditions 
(χ2(2) = 1.94, P=0.47). However, the percentage of responders who had only 1-8 encounters 
with a provider in the last 18 months (32%) was lower than the percentage of non-
responders (42%) with this number of encounters (χ2(2) = 9.34, P=0.009). Furthermore, the 
percentage of responders who were female (56%) was greater than the percentage of non-
responders who were female (46%) (χ2(1) = 7.51, P=0.006), and the percentage of 
responders who were ≥65 years of age (57%) was greater than the percentage of non-
responders who were ≥65 years of age (46%) (χ2(1) = 9.66, P=0.002).
Item diagnostics
Of the 78 items in the draft PETS measure, three items were removed due to extensive 
missing data (i.e., at least 25% missing), including one item each from the difficulty with 
taking medications, medical/healthcare expenses, and confusion/concern about medical 
information domains. The majority of inter-item correlations (60%) in the full 78 × 78 item 
correlation matrix were rho ≥ 0.30 (a medium-sized correlation) [46]. Four more items were 
removed from the draft measure due to high inter-correlation(s) (rho ≥ 0.80) with at least 
one other item and a subsequent judgment of content overlap amongst those items, including 
one item each from the difficulty with taking medications, medical/healthcare expenses, 
confusion/concern about medical information, and physical/mental exhaustion domains. We 
also removed the seven items of the healthcare provider domain due to lack of conceptual fit 
with the treatment burden construct. Positive interpersonal qualities of one's provider are 
better construed as features that might lessen treatment burden, rather than contribute to it 
(see [47]). Finally, one other item was removed due to equally high inter-item correlations 
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with two different domains (medical/healthcare expenses and confusion about medical 
information); hence, it could not easily be mapped to a single domain. The excluded items 
and full results can be found in Online Resource Supplement 2.
All items in the exercise/physical therapy, diet, and medical equipment domains had 
substantial amounts of missing data (46% to 61%) due to skip patterns based on preceding 
yes/no screening questions and thus were excluded from the CFA. Furthermore, after 
deliberation, three items addressing barriers to medical appointments with low correlations 
with other items within the medical appointments domain were also excluded from CFA due 
to lack of conceptual fit. Thus, 48 items were retained from the PETS measure for 
subsequent testing. See Online Resource Supplement 2 for a record of all item diagnostics 
results.
Factor analysis and scaling of the PETS
The first CFA model tested featured 11 content domains and was based on the previously 
outlined conceptual framework [3] with some modification after review of item diagnostics 
(see above). Domains included learning about health conditions and care, medications, 
difficulty with taking medications, medical appointments, monitoring health, interpersonal 
challenges, medical/healthcare expenses, confusion/concern about medical information, 
difficulty with healthcare services, role/social activity limitations due to self-care, and 
physical/mental exhaustion due to self-care. This model assumed correlations of all factors, 
an assumption justified by the large degree of inter-correlation amongst all items (see 
above). The 11-factor correlated model provided a satisfactory fit to the data (CFI=0.98, 
TLI=0.97, RMSEA=0.043, 90% CI [0.039, 0.046]). Estimated correlations between the 
factors appear in Table 2.
After review of the domain inter-correlations as well as the item content of each domain, a 
slightly modified factor structure was proposed. To obtain greater parsimony, we combined 
domains that were highly-correlated (rs ≥ 0.70) and deemed by us to have similar item 
content. Based on this rationale the “learning about health conditions/care” and “confusion/
concern about medical information” domains were combined into a single domain labeled, 
“medical information.” Further, the “medications” and “difficulty with taking medications” 
domains were consolidated into a single “medications” domain. Two items indicative of 
distress with taking medications – bother due to reliance on medicines and bother due to side 
effects of medicines – were analyzed separately. These two items assessing psychological 
bother appear to be conceptually distinct from the other seven items within the medications 
domain that assess the behavioral ease with which medications are taken and integrated into 
everyday life. The resulting 9-factor model featuring 46 items (less the two bother items) 
was subjected to CFA, which provided a satisfactory fit to the data (CFI=0.98, TLI=0.97, 
RMSEA=0.045, 90% CI [0.041, 0.049]). For comparative purposes, a one-factor model was 
also tested (all items loading on a single domain). This model provided a sub-optimal fit to 
the data (CFI=0.84, TLI=0.84, RMSEA=0.106, 90% CI [0.103, 0.108]). Hence, nine multi-
item scales (46 items total) were generated using the pro-rated, standardized scoring as 
defined above. The two medication bother items were retained with scores standardized to 
the 0-100 scale. Both were analyzed separately as single-item indicators in the subsequent 
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validation analyses. The multi-item scales represented the following domains: medical 
information, medications, medical appointments, monitoring health, interpersonal 
challenges, medical/healthcare expenses, difficulty with healthcare services, role/social 
activity limitations, and physical/mental exhaustion. Mean scores, score ranges obtained, 
percentage scoring at floor (lowest possible burden score) and ceiling (highest possible 
burden score), and the skewness statistics for the total and site-specific samples are shown in 
Table 3. Mean burden scores were generally higher in the HCMC patients than the Mayo 
Clinic patients. Overall, scale scores were positively skewed toward lower burden, with the 
medications, medical appointments, interpersonal challenges, and role/social activity 
limitations scales showing greatest skewness and the most floor effects. The 48-item version 
of the PETS can be found in the appendix.
Reliability
As shown in Table 4, all nine multi-item scales showed good internal consistency reliability. 
Cronbach's alpha coefficients were well above threshold for adequate reliability (alpha ≥ 
0.70) [45].
Construct and known-groups validity
As indicated in Table 4, all nine PETS scales were significantly correlated with scores of 
conceptually-related constructs assessed in established measures. Higher PETS scores (i.e., 
more burden) were associated with greater chronic condition distress (Chronic Condition 
Distress scale), more bother due to medication side effects (TSQM side effects), less 
medication convenience (TSQM convenience), lower self-efficacy for managing chronic 
illness (PMCSM), poorer physical and mental health (PROMIS-10), and lower patient-rated 
convenience of healthcare services. Magnitudes of most of these correlations (81%) were 
medium-size or greater (rho ≥ 0.30) [46] supporting construct validity of the PETS scales. 
PETS scores were largely uncorrelated with patient data extracted from the medical record. 
While having more diagnosed conditions was associated with more problems with medical/
healthcare expenses (rho=0.15) and having more documented encounters with providers was 
associated with more medication problems (rho=0.25), more role/social activity limitations 
(rho=0.15), and more physical/mental exhaustion due to self-care (rho=0.19), these 
correlations were relatively small in magnitude. No other correlations between these medical 
record variables and PETS scale scores were significant.
Mean PETS scale scores were also compared across distinct patient groups (i.e., known-
groups validity). As shown in Figure 1, patients who have difficulty reading and 
understanding written medical information (i.e., lower health literacy) reported significantly 
more treatment burden in 8 of 9 PETS domains compared to those without such difficulty.
Furthermore, compared to those who reported 100% adherence to medications prescribed by 
their doctor(s), those adhering to medications ≤ 80% of the time reported significantly more 
treatment burden in 8 of 9 PETS domains (see Figure 2).
Finally, compared to patients indicating no or only a “a little” financial difficulty due to their 
medical treatment or physical condition, those indicating financial difficulty “somewhat” or 
more reported significantly greater treatment burden in all PETS domains (see Figure 3).
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Validation analyses were also conducted on the two single-item indicators of medication 
bother – bother due to reliance on medicines and bother due to side effects of medicines. 
Greater bother due to reliance on medicines was significantly correlated with more chronic 
condition distress (rho=0.42), less convenience of medication (rho=-0.31), lower self-
efficacy (rho=-0.32), and poorer overall physical (rho=-0.40) and mental health (rho=-0.37) 
(all Ps<.001). Greater bother due to medication side effects was also significantly correlated 
with more chronic condition distress (rho=0.40), less convenience of medication 
(rho=-0.33), lower self-efficacy (rho=-0.32), and poorer overall physical (rho=-0.27) and 
mental health (rho=-0.28) (all Ps<.001). Both bother items were correlated with the number 
of prescription medications being taken (rhos=0.16, Ps<.005); however, neither item was 
correlated with the number of diagnosed conditions (rhos≤0.02).
Discussion
Substantial burden arises from the complexity of treatment regimens, including the self-
management that is often required of patients to maintain health and avoid disease 
progression. This is especially true for those who must manage multiple chronic health 
conditions. With its potential to negatively impact clinical outcomes like adherence, 
treatment burden would seem an important issue to understand and assess. In this study, we 
describe the development and validation of the Patient Experience with Treatment and Self-
Management (PETS), a comprehensive measure of treatment burden that operationalizes 
issues previously outlined in a patient-informed conceptual framework of general treatment 
burden (i.e., non-condition specific). Content and face validity of the PETS were ascertained 
through a review by key stakeholders and patient cognitive interviews. A cross-sectional 
survey of 332 people with multiple chronic conditions provides initial evidence of the 
measure's reliability, construct validity, and ability to detect differences in meaningful 
groups of patients. Furthermore, the PETS appears to provide information about the patient 
that cannot be gleaned from a review of the medical record.
The PETS measure validated in this study contains 48 items, most of which (46) are 
organized into 9 content domains (see appendix). Factor analyses supported the scoring of 
these domains into 9 multi-item scales. Two items indicative of medication bother (reliance 
and side effects) are scored as single-item indicators. For this initial validation, we chose to 
err on the side of having more domains (i.e., scores) that are clinically meaningful and easy 
to interpret. Future studies will evaluate the replicability of the current model and investigate 
the viability of additional scoring algorithms that consolidate the domains into aggregated 
dimensions. Dimensional or “component” scoring can be a useful means of summarizing the 
health or well-being status of a population and is utilized in other well-established measures 
like the SF-36 and PROMIS Global-10 [36,48]. The inter-correlations of the domains (see 
Table 2) would appear to justify further investigation of dimensional scoring.
We chose to set aside several items and domains for later analysis and scrutiny. Items in the 
exercise/physical therapy, diet, and medical equipment content domains were each preceded 
by a screening question that invoked a skip pattern. Hence, there was a considerable amount 
of data missing for these items. We also set aside three items addressing barriers to getting to 
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medical appointments. These items were less well correlated with the other items in the 
medical appointments domain. One or more of these items may be retained in future tests.
Clinical utility of the PETS could be considerable, and remains to be assessed in future 
trials. Clinicians tend to know little about the burden that their recommendations place upon 
their patients, and how this burden might result in lesser adherence, attendance at visits, and 
poorer outcomes. We believe that a clinically-oriented scale of treatment burden would be an 
impressive adjunct to clinical care, and could guide clinicians and patients into joint 
discussions about the usefulness of recommendations and prioritizing of best next steps to 
take together. The lack of correlation with objective information from the medical record 
(i.e., numbers of conditions and provider visits) would seem to indicate that treatment 
burden is a subjective experience ideally assessed by patient self-report.
Finally, it is noteworthy that the term “burden” does not appear anywhere within the 
measure itself (including the name). During our initial qualitative exploration of the concept, 
some patients felt that this term had too negative a connotation, implying that a respondent is 
somehow failing or does not have the requisite skill to accomplish certain critical tasks. 
Others identified self-management simply as “the work I have to do” [47]. Hence, we felt it 
appropriate to remove any references to “burden” in the measure. To further diminish any 
perception of negative tone, for some content domains we opted to use balanced “agree/
disagree” or “easy/difficult” response scales, in lieu of always assessing the frequency of “a 
problem.”
Limitations
Validation of a self-report measure does not occur in a single study, rather it is a process that 
unfolds over time as psychometric evidence accumulates. While this study provides initial 
evidence of the PETS' reliability and validity in a diverse patient sample, its cross-sectional 
design is a limitation. We are currently undertaking a large-scale, prospective validation 
study of the PETS to determine among other things its responsiveness to change, predictive 
validity, test-retest reliability, replicability of its factor structure, and viability of alternative 
scoring algorithms. This will be particularly important to determine as some of the PETS 
domain scales yielded scores that were somewhat positively skewed toward the favorable 
end (i.e., less burden) with substantial numbers scoring at the floor. While it is not unusual to 
observe such skewness in scores of patient-reported measures of health concepts [49], it will 
be important to determine in future tests whether any skewness of PETS domain scores 
compromises the ability to detect change in patient status. Finally, as this study was 
conducted in the United States, it is possible that some issues represented in the PETS may 
be less relevant to patients of other global health care systems. For instance, medical and 
healthcare expenses may be of less concern to people residing in countries with government-
subsidized health care systems.
Conclusion
While self-report measures of treatment burden exist, current measures target specific 
diseases [50,19], treatment modes [17,51], circumscribed aspects of burden like perceived 
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task difficulty [18], or are lacking in comprehensiveness [52]. Developing measurement that 
comprehensively assesses the many domains of treatment burden that can be applied across 
chronic conditions or with multiple chronic conditions, is still in its infancy. We believe that 
such a measure would have great value. First, it could provide a novel, patient-centered 
outcome for comparative effectiveness studies [53,54] and epidemiologic and health services 
research designed to identify subgroups of patients at risk for poor outcomes [55]. Second, it 
could be used as a performance measure for healthcare entities or help evaluate innovative 
healthcare delivery models like patient-centered medical homes, nurse-coordinated care, or 
self-management support [56-59]. Third, healthcare providers could use information on 
treatment burden to identify patients who may have problems with adherence to medical 
regimens or who are overwhelmed and may benefit from a more minimally disruptive 
medicine [16]. We are currently undertaking work with the PETS in all three of these areas, 
including construction of shorter versions of the measure. The breadth and richness of the 
measure will allow for comparisons across a wide variety of healthcare settings and patient 
conditions. As there is no calculated total score, users may choose to use only those PETS 
scales that are suited to their study or clinical setting.
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Refer to Web version on PubMed Central for supplementary material.
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Appendix: The 48-item version of the Patient Experience with Treatment 
and Self-management (PETS): a measure of perceived treatment burden
Domain / Item
Medical information: How easy/difficult has it been to … (Responses: very easy, easy, neither easy nor difficulty, 
difficult, very difficult, not applicable)
 learn about your health problem(s)?
 learn what foods you should eat to stay healthy?
 find information on the medications that you have to take?
 understand changes to your treatment plan?
 understand the reasons why you are taking some medicines?
 find sources of medical information that you trust?
 understand advice from different healthcare providers?
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Domain / Item
Medications: How much of a problem has it been for you to … (Responses: not at all, a little, somewhat, quite a bit, 
very much)
 organize your medicines?
 take more than one medicine every day?
 take your medicines several times each day?
 refill your medicines?
 adjust your medicines (including the amount, type, or time when you take it)?
 take your medicines as directed?
 plan your daily activities around your medicine schedule?
Single-item indicators of medication bother: How bothered have you been by … (Responses: not at all, a little, 
somewhat, quite a bit, very much)
 how much you have to rely on your medicine(s)?
 side effects of your medicine(s)?
Medical appointments: How much of a problem has it been for you to … (Responses: not at all, a little, somewhat, 
quite a bit, very much)
 make or keep your medical appointments?
 schedule and keep track of your medical appointments?
 make or keep appointments with different healthcare providers?
Monitoring health: How much of a problem has it been for you to … (Responses: not at all, a little, somewhat, quite a 
bit, very much)
 monitor your health behaviors, e.g., tracking exercise, foods you eat, or medicines you take?
 monitor your health condition, e.g., weighing yourself, checking blood pressure, or checking blood sugar?
Interpersonal challenges: How bothered have you been by … (Responses: not at all, a little, somewhat, quite a bit, 
very much)
 feeling dependent on others for your healthcare needs?
 others reminding you to do things for your health like take your medicine, watch what you eat, or schedule medical 
appointments?
 your healthcare needs creating tension in your relationships with others
 others not understanding your health situation
Medical & healthcare expenses: How easy/difficult has it been for you to … (Responses: very easy, easy, neither easy 
nor difficulty, difficult, very difficult, not applicable)
 plan for the future because of your medical expenses?
 pay for healthy foods?
 pay for all of your medical expenses?
 pay for your medicines?
 understand what is and what is not covered by your health insurance?
Difficulty with healthcare services: How much do you agree/disagree with the following? (Responses: strongly agree, 
agree, disagree, strongly disagree, not applicable)
 Have problems with different healthcare providers not communicating with each other about my medical care
 Have to see too many different specialists for my health problem(s) or illness(es)
 Have problems filling out forms related to my healthcare
 Have problems getting appointments at times that are convenient for me
 Have problems getting appointments with a specialist
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Domain / Item
 Have to wait too long at my medical appointments
 Have to wait too long at the pharmacy for my medicine
Role and social activity limitations: How much has your self-care interfered with your … (Responses: not at all, a little, 
somewhat, quite a bit, very much)
 work (include work at home)?
 family responsibilities?
 daily activities?
 hobbies and leisure activities?
 ability to spend time with family and friends?
 ability to travel for work or vacation?
Physical and mental exhaustion: How often did your self-care make you feel … (Responses: never, rarely, sometimes, 
often, always)
 angry?
 preoccupied?
 depressed?
 worn out?
 frustrated?
Note. With the exception of items in the “difficulty with healthcare services” domain, all items reference a recall time 
period of the past 4 weeks. No recall time period is used for the difficulty with healthcare services items.
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Fig. 1. Mean PETS domain score comparisons by health literacy with 95% confidence intervals
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Fig. 2. Mean PETS domain score comparisons by medication adherence with 95% confidence 
intervals
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Fig. 3. Mean PETS domain score comparisons by self-reported financial difficulties with 95% 
confidence intervals
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Table 1
Demographic, medical, and other health-related characteristics of survey respondents 
(N=332)
Mean age in years (SD) 65.9 (11.0)
 Range 26 - 90
Gender (N, %)
 Female 185 (56%)
 Male 147 (44%)
Race (N, %)
 White 241 (73%)
 Black / African-American 51 (15%)
 Mixed 10 (3%)
 Asian 8 (2%)
 Native American / American Indian 6 (2%)
 Missing 16 (5%)
Hispanic / Latino ethnicity (N, %) 11 (3%)
Marital status (N, %)
 Married or living with partner 191 (58%)
 Not married 128 (39%)
 Missing 13 (4%)
Education level (N, %)
 Less than High school 22 (7%)
 High school graduate 67 (20%)
 Some college / Associate's degree 119 (36%)
 College graduate (B.A., B.S.) 70 (21%)
 Graduate school / Advanced degree 43 (13%)
 Missing 11 (3%)
Work status (N, %)
 Not working 217 (65%)
 Working full or part-time 99 (30%)
 Missing 16 (5%)
No. of chronic conditions (N, %)
 2 103 (31%)
 3 112 (34%)
 4 or more 117 (35%)
Median no. of conditions 3.0
Diagnosed chronic conditions (N, %)
 Hypertension 254 (77%)
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 Disorders of lipid metabolism (incl. hypercholesterolemia) 252 (76%)
 Diabetes mellitus (Type 1 or 2) 120 (36%)
 Osteoarthritis 119 (36%)
 Coronary artery disease 63 (19%)
 Asthma 47 (14%)
 Chronic kidney disease 44 (13%)
 Depression 44 (13%)
 Glaucoma 41 (12%)
 Chronic obstructive pulmonary disorder 34 (10%)
 Hepatitis (B and C) 28 (9%)
 Coronary Heart Failure 22 (7%)
 Rheumatoid Arthritis 15 (5%)
No. of provider encounters in last 18 months (N, %)
 1-8 106 (32%)
 9-17 99 (30%)
 18+ 127 (38%)
Median no. of encounters 13.5
Taking prescription medications? (N, %)
 Yes 310 (93%)
 No 3 (1%)
 Missing 19 (6%)
No. of prescription medications (N, %)
 1 11 (3%)
 2-3 80 (24%)
 4-5 97 (29%)
 6 or more 111 (34%)
 Missing 33 (10%)
Adherence to medications? (N, %)
 Always take all medications 260 (78%)
 Take all medications ≤80% of the time 51 (15%)
 Missing 21 (6%)
Any health insurance? (N, %)
 Yes 291 (88%)
 No 22 (7%)
 Not sure 3 (1%)
 Missing 16 (5%)
Medical treatment causing financial difficulties? (N, %)
 Not at all 158 (48%)
 A little 80 (24%)
 Somewhat or more 78 (24%)
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 Missing 16 (5%)
Difficulty reading and understanding written medical information? (health literacy) (N, %)
 Never or rarely 267 (80%)
 Sometimes, often, or always 50 (15%)
 Missing 15 (5%)
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